PENG Block With or Without PPD Block for Postoperative Analgesia After Total Hip Arthroplasty
Sponsored by Kirsehir Ahi Evran Universitesi
About this trial
Last updated a month ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 21 days ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
* Adults aged 18 years and older
* American Society of Anesthesiologists (ASA) physical status I-III
* Scheduled for elective primary total hip arthroplasty under spinal anesthesia
* Able to provide written informed consent
Exclusion Criteria
* ASA physical status IV or V
* Serious concomitant cardiac, respiratory, hepatic, or renal disease
* Known neuropsychiatric disorder
* Cognitive impairment preventing understanding or response to the Numeric Rating Scale (NRS)
* Coagulopathy
* Local anesthetic allergy
* Infection or scar at the block site
* Failed block
* Refusal to participate
* Signs of local anesthetic systemic toxicity after block
* Patients in the PENG plus PPD group who would be exposed to a total local anesthetic dose above 3 mg/kg in patients weighing less than 50 kg
* Revision total hip arthroplasty
* Total hip arthroplasty planned for fracture
